NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-99

  1. 405 Posts.
    Totally agree, one of the best threads I've seen. Well researched posts, links to source info, well written and respectful. Really informative and appreciated. Cheers
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.